Q1 2018 EPS Estimates for UnitedHealth Group Inc Boosted by Jefferies Group (UNH)

UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at Jefferies Group boosted their Q1 2018 EPS estimates for shares of UnitedHealth Group in a research note issued to investors on Tuesday. Jefferies Group analyst D. Windley now expects that the healthcare conglomerate will earn $2.99 per share for the quarter, up from their previous estimate of $2.90. Jefferies Group has a “Buy” rating and a $248.00 price target on the stock. Jefferies Group also issued estimates for UnitedHealth Group’s Q2 2018 earnings at $2.97 EPS, Q3 2018 earnings at $3.17 EPS, Q4 2018 earnings at $3.44 EPS, FY2018 earnings at $12.56 EPS and FY2019 earnings at $14.41 EPS.

Several other brokerages have also issued reports on UNH. Argus lifted their target price on shares of UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday. Deutsche Bank lifted their target price on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday. Citigroup lifted their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday. Piper Jaffray Companies reiterated a “buy” rating and set a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Finally, Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $269.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $241.30.

Shares of UnitedHealth Group (NYSE UNH) traded up $4.73 during trading on Thursday, reaching $243.16. 6,234,000 shares of the company’s stock traded hands, compared to its average volume of 3,634,767. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $243.90. The company has a market capitalization of $234,630.00, a price-to-earnings ratio of 22.70, a PEG ratio of 1.45 and a beta of 0.66. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same period in the previous year, the business posted $2.11 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis.

A number of institutional investors have recently modified their holdings of UNH. Capital International Investors increased its position in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after buying an additional 3,289,470 shares during the period. Janus Henderson Group PLC grew its position in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after buying an additional 2,264,242 shares during the period. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC grew its position in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after buying an additional 1,562,661 shares during the period. 86.09% of the stock is currently owned by institutional investors and hedge funds.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Q1 2018 EPS Estimates for UnitedHealth Group Inc Boosted by Jefferies Group (UNH)” was originally reported by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thestockobserver.com/2018/01/19/q1-2018-eps-estimates-for-unitedhealth-group-inc-boosted-by-jefferies-group-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply